OPKO Health, Inc.
49
0
0
38
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 55/100
20.4%
10 terminated/withdrawn out of 49 trials
79.2%
-7.3% vs industry average
16%
8 trials in Phase 3/4
61%
23 of 38 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (49)
Pharmacokinetics, Pharmacodynamics, Safety and Tolerability Evaluation of CTAP101 Extended-release Capsules in Pediatric Participants
Role: lead
Phase 3 Safety and Efficacy Study of CTAP101 Extended-release Capsules in Children With Secondary Hyperparathyroidism
Role: lead
Safety and Efficacy Phase 3 Study of Long-acting hGH (MOD-4023) in Growth Hormone Deficient Children
Role: lead
Long Term Follow up Study of Long-acting hGH (MOD-4023) in Growth Hormone Deficient Children
Role: lead
Safety, Efficacy, PK and PD of CTAP101 (Calcifediol) ER Capsules for SHPT in HD Patients VDI
Role: lead
Safety and Efficacy of Rayaldee for Treating Mild to Moderate COVID-19
Role: lead
Repeated-dose Safety, Efficacy, Pharmacokinetic and Pharmacodynamic of CTAP101, Immediate-release Calcifediol, High-dose Cholecalciferol, and Paricalcitol Plus Low-dose Cholecalciferol in Patients With Secondary Hyperparathyroidism, Chronic Kidney Disease 3-4 and Vitamin D Insufficiency
Role: lead
A Phase 3, Multicenter Study To Evaluate The Efficacy And Safety Of MOD-4023 In Adults With Growth Hormone Deficiency
Role: lead
Effects and Safety of OPK-88004 Doses in Men With Signs and Symptoms of Benign Prostatic Hyperplasia (BPH)
Role: lead
Safety and Efficacy Study of MOD-4023 to Treat Children With Growth Hormone Deficiency
Role: lead
Effects and Safety of OPK-88003 Dose Escalation in Type 2 Diabetes Subjects
Role: lead
A Study of LY2944876 in Healthy Japanese and Non-Japanese Participants
Role: lead
A Study to Compare a New Drug for Type 2 Diabetes to Placebo and to a Treatment Already Available for Type 2 Diabetes
Role: lead
A Study of a Long-Acting r-Factor 7a (Factor VIIa) in Adult Men With Hemophilia A or B
Role: lead
Quality of Life and Visual Acuity of Visglyc Eye Drops on Dry Eye Patients
Role: lead
Efficacy and Safety of a Intra-articular Injection, ENKO1, in Patients With Symptomatic Knee Osteoarthritis.
Role: lead
A Clinical Study Investigating the Comparability of Somatrogon in Two Different Drug Product Presentations
Role: lead
Safety and Efficacy Phase 2 Study of Long-acting hGH (MOD-4023) in Growth Hormone Deficient Children
Role: lead
A 4-Week Safety Study of Oral ELND005 in Young Adults With Down Syndrome Without Dementia
Role: lead
ELND005 in Patients With Mild to Moderate Alzheimer's Disease
Role: lead